For Sponsorship and Exhibition Queries
Please Contact:
Samuel Rangare
Sponsorship & Exhibition Manager
Email Us:
sales@epomec.ae
Call Us:
+971 54 279 6581
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com
Santen Pharmaceutical is one of the world’s leading specialist ophthalmic pharmaceutical companies, founded in Japan over a century ago and now serving patients all over the world. We’re the ophthalmology market leader in Japan. We’ve been active in the European market since 1994 and are enjoying strong growth in EMEA (Europe, Middle East, Africa) and worldwide. We’re passionate about improving eye health and vision for patients and making beneficial treatments accessible to patients and healthcare systems. With our sole focus being ophthalmology, we can assess, respond and act quickly in this specialist field where we have deep knowledge and experience.
With our focus on the sense of eyesight, there’s a huge and unique opportunity to improve quality of life for patients while sustaining a strong and effective commercial organisation. As populations age, patient numbers are growing, driven by conditions like glaucoma and retinal disorders. The prescription ophthalmic pharmaceutical market is growing rapidly as new treatment and diagnosis methods emerge from evolving technology. There are significant unmet patient needs in ophthalmology.
Prescription ophthalmic pharmaceuticals are our core business, accounting for over 80% of our global net sales. We also provide over the counter eye treatments and medical devices as well as nutritional products for eye health. In EMEA, we are a leader in glaucoma and dry eye treatment – areas in which our portfolio serves every stage and type of disease. We are also growing our range in eye infections, allergies, and devices for vision correction and glaucoma surgery.
Our mission is simple – we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose.
EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. With over 200,000 employees across 150 countries, 650 operations facilities and 18,000 stores, in 2024 the Company generated consolidated revenue of Euro 26.5 billion. Its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. EssilorLuxottica is home to the most advanced lens technologies including Varilux, Stellest and Transitions, the most iconic eyewear brands including Ray-Ban and Oakley, the most desired luxury licensed brands and world-class retailers including LensCrafters and Sunglass Hut. The Company’s OneSight EssilorLuxottica Foundation has given access to sustainable vision care to more than 760 million people in underserved communities.
ESTABLISHED IN 1994, MEDICALS INTERNATIONAL IS A DISTRIBUTOR OF SPECIALIZED MEDICAL AND OPTICAL SUPPLIES TO THE MENA REGION, CYPRUS, GREECE, AZERBAIJAN & TÜRKİYE WITH 19 OFFICES OPERATING REGIONALLY.
Medicals International is headquartered in Lebanon and caters to a wide range of clients including the region’s top tier medical institutions and establishments.
Medicals International has distribution channels dealing in product lines as well as medical equipment in the fields of vision care, ophthalmology, dentistry, and critical care.
Medicals International runs smaller subsidiaries in each of the territories it covers, which creates four major advantages:
With a vast product portfolio of specialized international brands and over 30 years of solid experience in the industry, Medicals International has established itself as one of the leading medical distribution firms in the region.
Established in 1984, AMICO Group is a leading distributor of medical devices across the MENA region, with a footprint in 12 countries. AMICO Group excels in delivering cutting-edge medical technologies in areas such as ophthalmology, orthopedics, neurosurgery, dermatology, general surgery and wound, ENT, Vision Care, spinal surgery and IVD.
AMICO Group distinguishes itself by not only offering the latest in medical technology but also by providing comprehensive medical education and training to specialists. This dual focus ensures that healthcare professionals are well-equipped with the newest innovations to deliver superior patient care. AMICO Group’s dedication to technology, education, and innovation has solidified its status as a trusted partner for healthcare providers throughout the MENA region.
ZEISS is an internationally leading technology enterprise operating in the optical and optoelectronics industries. As a company wholly owned by a foundation, ZEISS is rooted in and committed to responsibility in all its activities. As a pioneer of scientific optics, we continue to challenge the limits of human imagination. With our passion for excellence, we create value for our customers and inspire the world to see in new ways.
The company was founded in 1846 by Carl Zeiss, who anchored precision, a commitment to innovation and the creation of real value for customers and society. In 1889, Ernst Abbe established the Carl Zeiss Foundation in memory of his partner as the sole owner of ZEISS, until today the foundation is exclusively committed to promoting science and progress. As a pioneer of corporate responsibility ZEISS is following a clear path: enabling customers to achieve their goals with value-added solutions developed and manufactured in a responsible manner.
Today, about 45,000 employees globally in around 50 countries work hard to fulfill and exceed customer expectations. They generated annual revenue totaling more than 15 billion euros (FY 2023/24) in the four ZEISS segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology. Currently, 15 percent of revenues are invested in science and R&D. ZEISS believes that innovation and technology are the key to a sustainable future and solutions for global challenges.
In 2002, Carl Zeiss Meditec AG, as it is known today, was created from the merger of the ZEISS Ophthalmology division with Asclepion-Meditec AG, a medical lasers specialist. On 22 July 2002, the Carl Zeiss Meditec AG shares were traded on the Neuer Markt for the first time, making it a publicly traded. Since then, the company has been striving to shape medical progress, efficiency and access to healthcare through innovative technology and support doctors to improve their patients’ quality of life. The Company does this by combining diagnostics technology with therapy and surgical solutions that optimize customers’ workflows to more effectively diagnose and treat diseases. And thus, out of a ZEISS division steeped in optical legacy and a nascent start-up within that division emerged to what is now a world leader in ophthalmology and microsurgery: Carl Zeiss Meditec AG.
Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, skin care, eye care, aesthetic care, specialty care and regenerative care. Over 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (~1,200 patents).
Manufacturing operations – located in Italy – are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partnersin +120 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.
Fidia has more than 1,600 global employees and boasts a turnover exceeding €463 million (2023), nearly 50 percent of which is generated abroad.
Orchidia Pharmaceutical Ind. is an outstanding Egyptian model specialized in the production of pharmaceutical ophthalmic products. We are ranked first in terms of total sales value with the highest growth rate in the Egyptian ophthalmology market.
We have accomplished such unprecedented success because we believe we can. We have faith in our strength, and we forge our own unique model of success.
Orchidia Pharmaceutical Ind. currently exists in 38 countries. We have an effective and scaling approach from registration up to physical presence and promotion
Rayner is leading the way in ophthalmic innovation with IOLs and ophthalmic solutions designed to provide surgeons and patients with the best visual outcomes. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.
With more than 70 years of continuous growth and experience, we now sell to over 80 countries. Our mission is to deliver innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in us to improve sight and quality of life.
Rayner has a broad portfolio of products across the patient pathway, including monofocal and premium Intraocular Lenses (IOLs), Ophthalmic Viscosurgical Devices (OVDs), the Sophi Phaco platform and RayPRO, our patient outcomes digital platform.
RayOne Galaxy, Rayner’s next-generation spiral IOL platform, has been meticulously engineered to redefine the way presbyopia patients experience the world. When patient satisfaction is nonnegotiable, the RayOne Galaxy emerges as a new premium lens solution designed to eliminate dysphotopic compromise.
A proprietary AI engine trained on patient outcomes was used to create a new and unique optical spiral. The resulting design provides optimised visual acuity, a continuous full range of vision, and reduced dysphotopsia.
Rayner’s state-of-the-art global headquarters and manufacturing plant are in Worthing on the South Coast of the UK. Rayner also has regional offices in Berlin, Kuala Lumpur, Lille, Madrid, Milan, Mumbai, New York, Seattle, Sydney and Warsaw.
Rayner is a British company and the only manufacturer of intraocular lenses in the UK.
Biotech Healthcare is a global leader in ophthalmic innovation, delivering advanced intraocular lenses and surgical technologies for over 25 years. Present in 110+ countries, the company combines robust R&D, stringent quality standards, and surgeon partnerships to make advanced eye care accessible worldwide.
SO has been a global leader in diagnostic ophthalmic instruments for over fifty years. Since its inception, the company has experienced continuous growth, driven by the visionary leadership of its founders, Mr. Sergio Mura and Mr. Giuseppe Matteuzzi. Under their guidance, CSO has expanded its market presence, becoming an undisputed leader in the industry.
Recently, CSO has further advanced its capabilities by expanding its manufacturing facilities with new production lines and enhancing its R&D department by recruiting additional engineers and software developers.
With a highly efficient and widespread team of employees and sales representatives, CSO has established itself as a strong player in the international market.
Among its most innovative products are the MS-39 and OSIRIS, which set new standards in diagnostic technology. The MS-39 is a state-of-the-art OCT device combined with a Placido disk corneal topographer, offering unparalleled precision in anterior segment tomography. It is considered one of the most advanced solutions for corneal and anterior segment analysis, ensuring exceptional accuracy for a wide range of clinical applications.
The OSIRIS aberrometer, equipped with groundbreaking PWS technology, enables highly detailed wavefront analysis by capturing up to 45,000 points, providing eye care professionals with an unmatched level of diagnostic information for personalized treatments.
In addition to these flagship products, CSO offers other instruments such as the COBRA+, an advanced and user-friendly fundus camera, the SIRIUS+, a combination of a Scheimpflug camera and corneal topographer, representing the forefront of corneal tomography. The company has also upgraded all of its slit lamps and the PERSEUS endothelial microscope with LED light sources.
CSO’s product portfolio continues to grow with newly designed refraction units made from innovative materials, complemented by a wide selection of chairs and drawer units.
Excellent hi-care was established in 1995 manufacturing and marketing of Intraocular lenses and ophthalmic surgical products. (Implantable Contact Lens(ICL), Toric Hydrophobic and Hydrophilic Lens, Trifocal Hydrophobic and Hydrophilic Lens, Multifocal Hydrophobic and Hydrophilic Lens, Opthalmic Solution Lens,Hydrophobic Foldable Intraocular lenses, 360 degree Hydrophilic Acrylic Foldable IOLs, PMMA Single Piece IOls and Ophthalmic knives/blades). The products are manufacturing as per Good manufacturing practices with state of the art technology. Our products are well recognized and using in leading eye care institutions and ophthalmologists in more than 35 countries worldwide.
Our company complies ISO 13485:2016 quality management systems and most of our products are CE certified to confirming the products are manufactured as per international quality standards.
Founded in the United Arab Emirates in 2017 by a private and professional proprietor. Euyuncare is a trading company of Ophthalmic equipment, Implantable Phakic Contact Lens and EDOF IOLs, Low Vision Aid Devices and Technology, Instruments, Ophthalmic Consumables, Human Tissue and Special Contact Lenses.
We are dedicated to build and establish relationships with manufacturers of leading technology in the optical industry.
We are committed to delivering high-quality ophthalmic products and solutions coupled with exceptional service. We have expanded to become a market leading trading companies that provides high-quality care and cost-effective ophthalmic products & correction solutions within our portfolio of hospitals, clinics and medical centers in the UAE.
HEIL PHARMA is a certified (CE – MDR) manufacturer of Ophthalmic Viscoelastic Devices, Cannulas, and Blades. Having rich traditions, whose rich traditions are deeply rooted in personal integrity, respect for individuals and customer satisfaction.
Since 1895, OCULUS has been a trusted partner to eye care professionals around the world.
With a deep commitment to precision and innovation, every OCULUS device is designed and manufactured with care at our headquarters in Germany.
Visit us at our booth to explore the Pentacam® Cornea OCT –
the first device to combine Scheimpflug Tomography with OCT technology, uniquely designed for cornea specialists!
We will also be showcasing the Pentacam® AXL Wave and Corvis® ST.
Optico Ltd is a British manufacturer with decades of expertise in precision ophthalmic microsurgical instrumentation. Trusted by surgeons worldwide, they combine traditional craftsmanship with modern engineering to deliver instruments that offer exceptional control, balance and reliability in the operating theatre.
Working in close partnership with leading ophthalmologists, Optico continuously refines and develops solutions that support the evolving needs of surgery. As their international presence expands, the commitment remains clear: precision without compromise, innovation driven by surgical insight and instruments designed to help surgeons achieve consistently outstanding patient outcomes.
OSAS Medical has been driving healthcare innovation since 1998.
“For more than two decades, OSAS Medical has committed itself to delivering quality medical technologies that empower healthcare providers. Our success is built on trust, innovation, and service excellence. We look forward to continuing this journey with our partners and clients saving lives, preventing vision loss and improving health together.”
Théa is a pioneering independent European pharmaceutical company, dedicated to the research, development, and commercialization of innovative eye care solutions. With more than 30 years of expertise, Théa has become a leader in the field of eye care, offering a wide range of products that address the diverse needs of eye care professionals, pharmacists, and their patients. Headquartered in Clermont-Ferrand, France, this family-owned company is present in 75 countries worldwide. Its subsidiary, Théa Middle East, has been actively supporting the ophthalmology scientific community in the region for more than 10 years. Théa continues to lead worldwide in ophthalmic innovation, committed to improving the quality of life for patients through cutting-edge solutions in eye care.
SOLMED is a private company that supplies the latest ophthalmic diagnostic tools, treatment solutions, and surgical instruments across the healthcare sector in the Middle East and Africa. Since its founding in 2008, SOLMED has redefined eye-care standards. We remain true to our founding belief and have broadened our vision to establish SOLMED as the benchmark provider of high quality ophthalmic products.
We are a leading Manufacturer and Exporter of Micro Ophthalmic Surgical Instruments. Our Quality management system is certified with ISO 13485:2016 and our product also Europium standard. Our Quality control system is under strict supervision of technical experts.
PLUS SURGICALS was established with a mission to serve our beloved as respected customers more better by supplying best quality Stainless Steel and Titanium instruments. Our Quality instruments are exporting many countries all over the world. We are a regular participant of All India Ophthalmological Society conferences and all State ophthalmic societies of INDIA and many more in the foreign countries including American Academy Conferences.
We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.
For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in Ophthalmology.
Our medium-sized company backed up by an exclusive network of subsidiaries, agents, and partners makes us efficient and responsive in the market, with the ability to develop custom solutions for patients and partners. As family firm since our foundation, we have strong values that are shared by everyone from the boardroom to the factory.
Established in 1989, Zahrawi Group is a pioneer Medical Devices and Life Science Distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in Surgical, Medical, Nuclear Medicine, Diagnostic, and Analytical Lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.
Zahrawi Group is committed to improving people’s lives by introducing innovative Healthcare products, Smart solutions, and Outstanding services.
Sign up now to our newsletter
